Logo
x

Search

Subscribe Now

Five-Year

BMS Signs a Five-Year Agreement with Insitro to Develop Therapies for ALS and Frontotemporal Dementia

BMS Signs a Five-Year Agreement with Insitro to Develop Therapies for ALS and Frontotemporal Dementia

  • October 29, 2020
Janssen Reports Five-Year Data of Stelara (ustekinumab) in P-lll LTE Study for Severe Crohn's Disease

Janssen Reports Five-Year Data of Stelara (ustekinumab) in P-lll LTE Study for Severe Crohn's Disease

  • October 12, 2020
Sanofi and MD Anderson Sign a Five-Year Pact to Expedite Oncology Research and Development

Sanofi and MD Anderson Sign a Five-Year Pact to Expedite Oncology Research and Development

  • July 14, 2020
Emergent Signs a Five-Year Manufacturing Services Agreement with Janssen for Ad26.COV2-S to Treat COVID-19

Emergent Signs a Five-Year Manufacturing Services Agreement with Janssen for Ad26.COV2-S to Treat COVID-19

  • July 7, 2020
Eli Lilly Signs Five-Years License Agreement with Evox Therapeutics for its DeliverEX Platform

Eli Lilly Signs Five-Years License Agreement with Evox Therapeutics for its DeliverEX Platform

  • June 9, 2020
Novo Nordisk Signs a Five-Year Agreement with UVA Center for Diabetes Technology for Type 2 Diabetes

Novo Nordisk Signs a Five-Year Agreement with UVA Center for Diabetes Technology for Type 2 Diabetes

  • December 20, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.